NCT06789718View on ClinicalTrials.gov

Impact of GABA Probiotic Lactiplantibacillus Plantarum Lp815 on Sleep Outcomes in Participants with Self-Reported Sleep Disturbance

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

November 22, 2024

Study Completion Date

March 1, 2025

Conditions
Insomnia (moderate)
Interventions
DIETARY_SUPPLEMENT

GABA Probiotic Lactiplantibacillus plantarum Lp815 (5 Billion cfu/dose)

75 participants will be randomized into the study product group.

OTHER

Placebo

75 participants will be randomized into the placebo group.

DIAGNOSTIC_TEST

Optional Sub-Study: Neurotransmitter Urine Test

20 participants who opt-in to the sub-study will provide urine tests during baseline, day 2, day 4, day 7, day 14, day 28, and day 42 while simultaneously participating in the main-study.

Trial Locations (1)

90034

People Science, Inc., Los Angeles

All Listed Sponsors
lead

Verb Biotics LLC

INDUSTRY

NCT06789718 - Impact of GABA Probiotic Lactiplantibacillus Plantarum Lp815 on Sleep Outcomes in Participants with Self-Reported Sleep Disturbance | Biotech Hunter | Biotech Hunter